![Sensors | Free Full-Text | Technologies for Assessment of Motor Disorders in Parkinson's Disease: A Review Sensors | Free Full-Text | Technologies for Assessment of Motor Disorders in Parkinson's Disease: A Review](https://www.mdpi.com/sensors/sensors-15-21710/article_deploy/html/images/sensors-15-21710-g001.png)
Sensors | Free Full-Text | Technologies for Assessment of Motor Disorders in Parkinson's Disease: A Review
![Levodopa-Continuous Dopaminergic Stimulation in the Treatment of Parkinson's Disease: The Role of COMT Inhibitors Levodopa-Continuous Dopaminergic Stimulation in the Treatment of Parkinson's Disease: The Role of COMT Inhibitors](https://img.medscapestatic.com/slide/migrated/editorial/cmecircle/2004/3402/images/melamed/slide011.gif)
Levodopa-Continuous Dopaminergic Stimulation in the Treatment of Parkinson's Disease: The Role of COMT Inhibitors
![Treatment Strategies to Overcome End-of-Dose Failure With Oral and Transdermal Opioids | Semantic Scholar Treatment Strategies to Overcome End-of-Dose Failure With Oral and Transdermal Opioids | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4dda2089df33837e992a8b247ad842dfe43f8a46/3-Table1-1.png)
Treatment Strategies to Overcome End-of-Dose Failure With Oral and Transdermal Opioids | Semantic Scholar
![The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram](https://www.researchgate.net/publication/259878880/figure/fig1/AS:202657848401940@1425328804772/Study-design-On-the-first-visit-we-changed-the-previous-opioid-drug-to-fentanyl-patch_Q320.jpg)
The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram
![End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease | SpringerLink End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00415-006-0320-z/MediaObjects/415_2006_320_f1.jpg)
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease | SpringerLink
![PDF) Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease PDF) Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease](https://www.researchgate.net/profile/Angelo-Antonini/publication/372580656/figure/fig1/AS:11431281178459942@1690924136751/Mechanistic-Depiction-of-OFF-Episodes-a-a-Graphical-representation-of-response-to_Q320.jpg)
PDF) Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease
![Clinical Use of On-Demand Therapies for Patients with Parkinson's Disease and OFF Periods | Neurology and Therapy Clinical Use of On-Demand Therapies for Patients with Parkinson's Disease and OFF Periods | Neurology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40120-023-00486-5/MediaObjects/40120_2023_486_Fig1_HTML.png)
Clinical Use of On-Demand Therapies for Patients with Parkinson's Disease and OFF Periods | Neurology and Therapy
![Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease | Neurology Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease | Neurology](https://n.neurology.org/content/neurology/89/7/e83/F1.large.jpg)
Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease | Neurology
![The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram](https://www.researchgate.net/publication/259878880/figure/fig3/AS:202657848401948@1425328804922/The-proportion-of-end-of-dose-failure-on-visit-1-and-visit-2-After-the-use-of-fentanyl.png)
The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram
![Levodopa-Continuous Dopaminergic Stimulation in the Treatment of Parkinson's Disease: The Role of COMT Inhibitors Levodopa-Continuous Dopaminergic Stimulation in the Treatment of Parkinson's Disease: The Role of COMT Inhibitors](https://img.medscapestatic.com/slide/migrated/editorial/cmecircle/2004/3402/images/melamed/slide009.gif)
Levodopa-Continuous Dopaminergic Stimulation in the Treatment of Parkinson's Disease: The Role of COMT Inhibitors
![CTN | Free Full-Text | Could New Generations of Sensors Reshape the Management of Parkinson's Disease? CTN | Free Full-Text | Could New Generations of Sensors Reshape the Management of Parkinson's Disease?](https://www.mdpi.com/ctn/ctn-05-00018/article_deploy/html/images/ctn-05-00018-g001.png)